Paper38332012
Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.
Tian C and 19 others. Nat Commun, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function. Papers, record 38332012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38332012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Natural Killer T-Cells | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Lymphocyte Activation | |
| Immunotherapy | |
| Macrophages | |
| Antigens, CD1d |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32325020 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 92254304 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82202022 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82101912 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82372778 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82071736 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed | ||
| 82371732 | National Natural Science Foundation of China (National Science Foundation of China) | PubMed |
Source PubMed
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23171661 | Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. | Brain | 2012 | https://conductscience.org/library/papers/23171661 | PubMed |
| 2 | 23761735 | BMP signaling in telencephalic neural cell specification and maturation. | Front Cell Neurosci | 2013 | https://conductscience.org/library/papers/23761735 | PubMed |
| 3 | 26042123 | Intravital imaging - dynamic insights into natural killer T cell biology. | Front Immunol | 2015 | https://conductscience.org/library/papers/26042123 | PubMed |
| 4 | 28419443 | Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice. | Immunology | 2017 | https://conductscience.org/library/papers/28419443 | PubMed |
| 5 | 19411762 | Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19411762 | PubMed |
| 6 | 36208623 | The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes. | Cell | 2022 | https://conductscience.org/library/papers/36208623 | PubMed |
| 7 | 30258446 | ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes. | Front Immunol | 2018 | https://conductscience.org/library/papers/30258446 | PubMed |
| 8 | 35944541 | Melanopsin retinal ganglion cells mediate light-promoted brain development. | Cell | 2022 | https://conductscience.org/library/papers/35944541 | PubMed |
| 9 | 32516575 | Distinct iNKT Cell Populations Use IFNγ or ER Stress-Induced IL-10 to Control Adipose Tissue Homeostasis. | Cell Metab | 2020 | https://conductscience.org/library/papers/32516575 | PubMed |
| 10 | 34343496 | CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment. | Cell | 2021 | https://conductscience.org/library/papers/34343496 | PubMed |
| 11 | 34106045 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. | Elife | 2021 | https://conductscience.org/library/papers/34106045 | PubMed |
| 12 | 31467405 | Dendritic cells in cancer immunology and immunotherapy. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31467405 | PubMed |
| 13 | 17259969 | Regulation of T-cell activation by the cytoskeleton. | Nat Rev Immunol | 2007 | https://conductscience.org/library/papers/17259969 | PubMed |
| 14 | 35552271 | LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35552271 | PubMed |
| 15 | 29614819 | Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29614819 | PubMed |
| 16 | 35210567 | VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/35210567 | PubMed |
| 17 | 33362769 | T Cell Motility─How Is It Regulated? | Front Immunol | 2020 | https://conductscience.org/library/papers/33362769 | PubMed |
| 18 | 17308126 | Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. | Cancer Res | 2007 | https://conductscience.org/library/papers/17308126 | PubMed |
| 19 | 30171164 | LFA-1 Ligation by High-Density ICAM-1 Is Sufficient To Activate IFN-γ Release by Innate T Lymphocytes. | J Immunol | 2018 | https://conductscience.org/library/papers/30171164 | PubMed |
| 20 | 29634943 | T Cell Dysfunction in Cancer. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29634943 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41755879 | Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design. | JACS Au | 2026 | https://conductscience.org/library/papers/41755879 | PubMed |
| 41493506 | Redefining cell therapy: CAR-engineered innate immune cells to conquer solid and hematologic malignancies. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41493506 | PubMed |
| 40995371 | Visualizing cellular interactions: intravital imaging in tumor microenvironment. | Front Immunol | 2025 | https://conductscience.org/library/papers/40995371 | PubMed |
| 40963926 | The first abdominal aortic aneurysm organoid model replicates complex microenvironment for in vitro disease study. | Theranostics | 2025 | https://conductscience.org/library/papers/40963926 | PubMed |
| 40718496 | CAR-iNKT cells: redefining the frontiers of cellular immunotherapy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40718496 | PubMed |
| 40698085 | Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis. | Front Immunol | 2025 | https://conductscience.org/library/papers/40698085 | PubMed |
| 40583406 | NKT cells-a generalist in disease treatment and a new key to unlock immunotherapy. | Immunotherapy | 2025 | https://conductscience.org/library/papers/40583406 | PubMed |
| 40514544 | Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design. | Nat Rev Immunol | 2025 | https://conductscience.org/library/papers/40514544 | PubMed |
| 40165901 | Inflammation and cancer: molecular mechanisms and clinical consequences. | Front Oncol | 2025 | https://conductscience.org/library/papers/40165901 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD1D | 912 | PubTator's text mining | https://conductscience.org/library/genes/912 | NCBI Gene |
| CDC42 | 998 | PubTator's text mining | https://conductscience.org/library/genes/998 | NCBI Gene |
| ITGA4 | 3676 | PubTator's text mining | https://conductscience.org/library/genes/3676 | NCBI Gene |
| VCAM1 | 7412 | PubTator's text mining | https://conductscience.org/library/genes/7412 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| SRA | PRJNA946041 |
Source SRA
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38332012
GET https://conductscience.org/api/papers/v1/38332012/references?page=2